Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral

Clover Health Investments, Corp.

Filed: Mar 30, 2026CIK: 0001801170
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Clover Health's board approved a CFO transition on March 30, 2026, signaling a change in financial leadership. While details remain undisclosed, this executive change could impact investor confidence and the company's strategic financial direction.

Key Takeaways

Board of directors approved CFO transition effective March 30, 2026

Specific details about the departing CFO and successor were not disclosed in the filing

2 more takeaways

Related Filings (1)

1 more filing from Clover Health Investments, Corp. in the last 90 days

Filing Overview

Form Type8-K
Filing DateMar 30, 2026
Item5.02
CategoryExecutive Change
CIK0001801170
Accession #0001801170
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
leadership transitionexecutive departure

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings